Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

Guardant Health aims to reshape how the U.S. gets screened for colorectal cancer, by claiming a groundbreaking FDA approval for a tumor-detecting blood test aimed at a population of about 120 million ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

A study by Pickhardt et al. in the most recent issue of the Annals of Internal Medicine reports a miss rate of approximately 10 percent for large (>5mm) precancerous polyps during conventional ...

A new European study on colonoscopies – the largest of its kind – has complicated results, and it’s left some people wondering whether they should have the procedure to screen for colon cancer. “I ...

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

On Sunday, the New England Journal of Medicine published the interim results of a landmark trial examining the effect of inviting people to colonoscopy screening. The paper, which STAT covered, ...

A Knoxville company has launched a blood test locally that could reshape how patients get one of the more unpleasant but essential medical tests: screening for colorectal cancer. The test, called ...

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

Screening for colorectal cancer could become much cheaper and less invasive.

I had rectal bleeding, the most common symptom of colon cancer in people under 45. I also had a family history of colon cancer, which pushed me to get a colonoscopy at 33. My out-of-pocket colonoscopy ...